Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...
Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...
After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...
Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...
This story mentions weight, weight loss, and/or GLP-1 drugs. In the last few years, GLP-1s, prescription weight loss ...
It seems demand is growing amongst women in perimenopause, menopause and postmenopause looking for multifaceted weight loss ...
In its Monday update, the FDA clarified that state-licensed compounding pharmacies and outsourcing facilities — which make ...
A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight ...
Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...
Telehealth company Hims & Hers Health (HIMS) witnessed a major dip in its stock recently despite reporting 95% revenue growth ...
Most compounded versions of popular ... thereby causing weight loss. Some people are overdosing on semaglutide, FDA warns Ozempic is approved by the FDA to treat Type 2 diabetes, but some doctors ...